Korsana Biosciences, Inc. (KRSA) Stock
Healthcare · Biotechnology · Member of Other US Stocks
Korsana Biosciences, Inc. (KRSA) closed at USD 34.32 on 2026-10-14, a change of +140.3 % over the past year, with a market capitalization of USD 1.53B.
Korsana Biosciences, Inc. recent closing prices
| Date | Close (USD) |
|---|---|
| 2026-10-14 | 34.32 |
| 2026-10-13 | 31.66 |
| 2026-10-12 | 34.04 |
| 2026-10-09 | 33.92 |
| 2026-10-08 | 33.51 |
| 2026-10-07 | 31.65 |
| 2026-10-06 | 31.77 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Korsana Biosciences, Inc. key figures
- Previous close
- USD 34.32 (2026-10-14)
- 1-year change
- +140.3 %
- Market cap
- USD 1.53B
- Enterprise value
- USD 244.37M
- P/E ratio (trailing)
- -4.43
- P/E ratio (forward)
- -9.46
- EPS (trailing)
- -7.60
- EPS (forward)
- -3.56
- PEG ratio
- n/a
- Price to book
- -4.29
- Revenue growth
- n/a
- Earnings growth
- n/a
- Dividend per share (trailing)
- 0.00
- Short ratio
- 0.14
- Employees
- 19
- Analyst consensus (third-party)
- strong_buy
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Korsana Biosciences, Inc.
Korsana Biosciences, Inc. develops therapeutic antibodies for the treatment of neurodegenerative diseases. The company has developed Therapeutic Targeting (THETA), a blood-brain barrier-penetrant shuttle platform designed to enhance central nervous system exposure of investigational therapies and enable delivery of large therapeutic molecules across the blood-brain barrier into the central nervous system. The company advances a pipeline of THETA-enabled therapeutics with an initial focus on neurodegenerative disorders. Its lead product candidate is KRSA-028, an anti-amyloid beta antibody for the treatment of Alzheimer's disease, which combines the THETA platform with elements of anti-amyloid beta approaches and targets a clinically relevant form of amyloid beta designed to improve brain uptake while reducing effects on reticulocytes. The company is also advancing a pipeline of additional THETA-enabled therapies for other neurodegenerative diseases. Korsana Biosciences, Inc. was incorporated in 2024 and is based in Waltham, Massachusetts.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Korsana Biosciences, Inc. and compare it with other stocks.
Analyze KRSAAll Other US Stocks stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Korsana Biosciences, Inc. shares.